Episode
Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical
- Podcast
- Outcomes Rocket
- Published
- Jun 23, 2026
- Duration seconds
- 698
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/outcomes-rocket-769427/episodes/using-ai-to-strengthen-clinical-confidence-in-procedures-with-will-mauldin-co-founder-and-ceo-of-rivanna-medical/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/outcomes-rocket-769427/using-ai-to-strengthen-clinical-confidence-in-procedures-with-will-mauldin-co-founder-and-ceo-of-rivanna-medical.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
AI in medtech is most valuable when it supports better clinical decisions, not when it replaces clinicians. In this episode, Alexis Anderson speaks with Will Mauldin, Co-Founder and CEO of Rivanna Medical, live from DeviceTalks Boston. Will explains how Rivanna is bringing AI-enabled imaging to clinical settings where providers have traditionally relied on blind or manual procedures, beginning with epidural anesthesia guidance and expanding into fracture detection. He shares how the company’s handheld spine guidance technology helps clinicians visualize the epidural space, use AI as a confirmation tool, and build confidence through consistent outcomes. Will also discusses broader medtech trends around AI, automation, connected devices, and robotics, along with funding challenges for mid-stage companies and Rivanna’s upcoming FDA milestones. Tune in and learn how AI-enabled imaging can improve safety, reduce bottlenecks, and support clinicians in high-demand care environments. Resources Connect and follow Will Mauldin on LinkedIn. Follow Rivanna Medical on LinkedIn and explore their website.